These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31040341)

  • 1. Intraperitoneal administration of fosfomycin, metronidazole, and granulocyte-macrophage colony-stimulating factor in patients undergoing appendectomy is safe: a phase II clinical trial.
    Fonnes S; Holzknecht BJ; Arpi M; Rosenberg J
    Sci Rep; 2019 Apr; 9(1):6727. PubMed ID: 31040341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma pharmacokinetics of fosfomycin and metronidazole after intraperitoneal administration in patients undergoing appendectomy for uncomplicated appendicitis.
    Fonnes S; Weisser JJ; Holzknecht BJ; Arpi M; Rosenberg J
    Fundam Clin Pharmacol; 2020 Aug; 34(4):504-512. PubMed ID: 31944378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shorter Total Length of Stay After Intraperitoneal Fosfomycin, Metronidazole, and Molgramostim for Complicated Appendicitis: A Pivotal Quasi-Randomized Controlled Trial.
    Fonnes S; Roepstorff S; Holzknecht BJ; Olesen CS; Olsen JHH; Schmidt L; Alder R; Gamborg S; Rasmussen T; Arpi M; Jørgensen LN; Rosenberg J
    Front Surg; 2020; 7():25. PubMed ID: 32432123
    [No Abstract]   [Full Text] [Related]  

  • 4. The Combination of Fosfomycin, Metronidazole, and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor is Stable in vitro and Has Maintained Antibacterial Activity.
    Fonnes S; Holzknecht BJ; Gasbjerg LS; Weisser JJ; Hallberg HW; Arpi M; Rosenberg J
    Drug Res (Stuttg); 2018 Jun; 68(6):349-354. PubMed ID: 29258152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase Ⅳ clinical trial for external use of recombinant human granulocyte-macrophage colony-stimulating factor gel in treating deep partial-thickness burn wounds].
    Liu J; Liao ZJ; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):542-8. PubMed ID: 27647071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.
    Gerhartz HH; Stern AC; Wolf-Hornung B; Kazempour M; Schmetzer H; Gugerli U; Jones TC; Wilmanns W
    Leuk Res; 1993 Feb; 17(2):175-85. PubMed ID: 8429694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-ranging study of recombinant human granulocyte-macrophage colony-stimulating factor in small-cell lung carcinoma.
    Hamm J; Schiller JH; Cuffie C; Oken M; Fisher RI; Shepherd F; Kaiser G
    J Clin Oncol; 1994 Dec; 12(12):2667-76. PubMed ID: 7989942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous administration of granulocyte-macrophage colony-stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia.
    Cannistra SA; DiCarlo J; Groshek P; Kanakura Y; Berg D; Mayer RJ; Griffin JD
    Leukemia; 1991 Mar; 5(3):230-8. PubMed ID: 1826536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma.
    Murray JL; Kleinerman ES; Jia SF; Rosenblum MG; Eton O; Buzaid A; Legha S; Ross MI; Thompson L; Mujoo K; Rieger PT; Saleh M; Khazaeli MB; Vadhan-Raj S
    J Immunother Emphasis Tumor Immunol; 1996 May; 19(3):206-17. PubMed ID: 8811495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of recombinant human granulocyte macrophage colony stimulating factor gel on treatment of full-thickness frostbite wounds on foot and hand].
    Sun ZA; Zhang XH; Xue Y; Zhou X; Chen XX; Gao XX; Yu JA
    Zhonghua Shao Shang Za Zhi; 2020 Feb; 36(2):117-121. PubMed ID: 32114729
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) after chemotherapy in patients with non-Hodgkin's lymphoma; a placebo-controlled double blind phase III trial.
    Kaku K; Takahashi M; Moriyama Y; Nakahata T; Masaoka T; Yoshida Y; Shibata A; Kaneko T; Miwa S
    Leuk Lymphoma; 1993 Oct; 11(3-4):229-38. PubMed ID: 8260897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
    Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM
    Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of recombinant human granulocyte-macrophage colony-stimulating factor in myelodysplastic syndrome and aplastic anemia.
    Takahashi M; Yoshida Y; Kaku K; Masaoka T; Moriyama Y; Nakanishi S; Kaneko T; Shibata A; Miwa S
    Acta Haematol; 1993; 89(4):189-94. PubMed ID: 8212999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics-First Versus Surgery for Appendicitis: A US Pilot Randomized Controlled Trial Allowing Outpatient Antibiotic Management.
    Talan DA; Saltzman DJ; Mower WR; Krishnadasan A; Jude CM; Amii R; DeUgarte DA; Wu JX; Pathmarajah K; Morim A; Moran GJ;
    Ann Emerg Med; 2017 Jul; 70(1):1-11.e9. PubMed ID: 27974169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human granulocyte-macrophage colony-stimulating factor hydrogel promotes healing of deep partial thickness burn wounds.
    Yan H; Chen J; Peng X
    Burns; 2012 Sep; 38(6):877-81. PubMed ID: 22652468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
    Lydaki E; Bolonaki E; Stiakaki E; Dimitriou H; Kalmantis T; Kalmanti M
    Pediatr Hematol Oncol; 1995; 12(6):551-8. PubMed ID: 8589000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of a new protocol decreasing antibiotic utilization after laparoscopic appendectomy for perforated appendicitis in children: A prospective observational study.
    Desai AA; Alemayehu H; Holcomb GW; St Peter SD
    J Pediatr Surg; 2015 Jun; 50(6):912-4. PubMed ID: 25812441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy. The Multicenter Study Group.
    Miwa S; Shibata A; Kaneko T; Moriyama Y; Kaku K; Ishida Y; Takahashi M
    Acta Haematol; 1992; 87(1-2):22-8. PubMed ID: 1585768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
    Pene R; Appelbaum FR; Fisher L; Lilleby K; Nemunaitis J; Storb R; Buckner CD
    Bone Marrow Transplant; 1993 Mar; 11(3):219-22. PubMed ID: 8467286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.